BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported fiscal fourth-quarter net income of $58 million.
The Boston-based company said it had net income of $1.17 per share. Earnings, adjusted for one-time gains and costs, were $1.24 per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.22 per share.
The provider blood management systems for health care providers and blood collectors posted revenue of $330.6 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $327.3 million.
For the year, the company reported profit of $167.7 million, or $3.31 per share. Revenue was reported as $1.36 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
